|
U.K. Report Recommends Overhaul of OTC Drug Regulation
Prioritizing changes to patient information on over-the-counter (OTC) medications could significantly ease the regulatory burden on both the OTC industry and regulators, concludes a recent report by the Better Regulation of OTC Medicines Initiative (BROMI), a public and private coalition led by the Medicines and Healthcare products Regulatory Agency (MHRA). This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives